Core transcriptional regulatory circuit-regulated IGF2BP3 stabilizes E2F2 mRNA via m6A modification in neuroblastoma
Carcinogenesis · 2025
DOI: 10.1093/carcin/bgaf040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von Pengcheng Yang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Neuroblastoma, Adenosine, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Neuroblastoma (NB) is a pediatric tumor with diverse outcomes and unknown underlying mechanisms. The core transcriptional regulatory circuit (CRC) and N6-methyladenosine (m6A) are key factors that control cell identity and fate. IGF2BP3 is an m6A reader protein that is transcriptionally regulated by CRC transcription factors (TFs). In NB, this molecule is abundantly expressed, and there is a clear correlation between its expression and a bad prognosis. We mechanistically demonstrated that IGF2BP3 promotes E2F2 mRNA expression through m6A, which is correlated with high risk and poor prognosis in NB patients. We showed that the CRC TF-IGF2BP3-E2F2 regulatory axis forms an oncogenic network that drives NB development and progression. Overall, we investigated the molecular mechanism by which IGF2BP3, a m6A-reading protein that is regulated by CRC TFs, regulates E2F2 mRNA expression in an m6A-dependent manner. This study highlights the therapeutic potential of disrupting this axis with m6A-targeted interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China.
- Department of Pediatric Surgery, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu 225000, China.
- Cardiothoracic Surgery Department, Children's Hospital of Soochow University, Suzhou, Jiangsu 215025, China.
- Department of Pediatric Surgery, Children's Hospital of Soochow University, Suzhou, Jiangsu 215025, China.
- Department of Medicinal Chemistry, Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, Jiangsu 210009, China.
ORCID-Profile: Pengcheng Yang, Jianwei Wang, Xiaolu Li, Di Wu, Zimu Zhang, Jian Pan
Förderung
- National Key R&D Program of China
- National Natural Science Foundation
- Natural Science Foundation of Jiangsu Province
- Jiangsu Province
- Suzhou Health Talent Training Project
- the Science and Technology Development Project of Suzhou City
- Suzhou "Science, Education and Strong Health" Project
- Jiangsu Provincial Health Commission
Zitieren
APA
Yang, P., Wang, J., Wu, Z., Zhuo, R., Chen, Y., Li, G., Tao, Y., Li, X., Fang, F., Wu, D., Yang, Y., Yin, H., Qian, G., Wang, H., Li, X., Yu, J., Yang, R., Xu, Y., Li, Z., …, & Wang, J. (2025). Core transcriptional regulatory circuit-regulated IGF2BP3 stabilizes E2F2 mRNA via m6A modification in neuroblastoma. Carcinogenesis. https://doi.org/10.1093/carcin/bgaf040
Vancouver
Yang P, Wang J, Wu Z, Zhuo R, Chen Y, Li G, et al. Core transcriptional regulatory circuit-regulated IGF2BP3 stabilizes E2F2 mRNA via m6A modification in neuroblastoma. Carcinogenesis. 2025. doi:10.1093/carcin/bgaf040
BibTeX
@article{Yang2025,
author = {Yang, Pengcheng and Wang, Jianwei and Wu, Ziheng and Zhuo, Ran and Chen, Yanling and Li, Gen and Tao, Yanfang and Li, Xiaolu and Fang, Fang and Wu, Di and Yang, Yang and Yin, Hongli and Qian, Guanghui and Wang, Hairong and Li, Xin and Yu, Juanjuan and Yang, Randong and Xu, Yunyun and Li, Zhiheng and Shi, Lei and Zhang, Zimu and Pan, Jian and Wang, Jian},
title = {Core transcriptional regulatory circuit-regulated IGF2BP3 stabilizes E2F2 mRNA via m6A modification in neuroblastoma},
journal = {Carcinogenesis},
year = {2025},
doi = {10.1093/carcin/bgaf040}
}
EUVIMED